|
VEPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.613900E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.756400E-03 |
| Stage1-vs-Stage3 |
3.715600E-01 |
| Stage1-vs-Stage4 |
4.224800E-01 |
| Stage2-vs-Stage3 |
2.988400E-02 |
| Stage2-vs-Stage4 |
4.917600E-03 |
| Stage3-vs-Stage4 |
1.451980E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.14903700074865E-14 |
| Normal-vs-Asian |
8.08879629943249E-11 |
| Caucasian-vs-AfricanAmerican |
8.975600E-01 |
| Caucasian-vs-Asian |
6.785400E-01 |
| AfricanAmerican-vs-Asian |
6.501000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
8.501200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.04449999760448E-08 |
| Normal-vs-Age(81-100Yrs) |
1.944950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.151800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.758900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.022100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.629100E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.443400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.465800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.136300E-02 |
| Classical-VS-Follicular |
4.18040000005337E-06 |
| Classical-VS-Other |
9.097400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.52349999948953E-07 |
| Tall-VS-Other |
6.840200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.358020E-01 |
| Follicular-VS-Normal |
8.47040000029331E-07 |
| Other-VS-Normal |
2.27199999999206E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14273043752655E-14 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
2.48900000054952E-07 |
|
|
